Indeed, the balanced reciprocal translocation t(9;22) (q34;q11) gives rise to a constitutively active tyrosine kinase oncoprotein, BCR-ABL, that is the causative and functional lesion of CML. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.